Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Evaggelidis, J. Konradsen, B. Nordlund, C. Pedroletti, H. Ljungberg (Stockholm, Sweden). Self-reported asthma control correlates with fraction of exhaled nitric oxide and lung function. Eur Respir J 2009; 34: Suppl. 53, 1200

Member's Comments

No comment yet.

Related content which might interest you: In current smokers fraction of exhaled nitric oxide is not associated with asthma symptoms Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010 Bronchodilator response and previous lung function decline in relation with exhaled nitric oxide levels in asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008 Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Source: Eur Respir J 2008; 31: 539-546 Year: 2008 Childhood wheezing phenotypes influence asthma, lung function and exhaled nitric oxide fraction in adolescence Source: Eur Respir J 2016; 47: 510-519 Year: 2016 Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma? Source: Eur Respir J 2002; 20: Suppl. 38, 196s Year: 2002 Exhaled nitric oxide is related to asthma control but not severity Source: Eur Respir J 2004; 24: Suppl. 48, 260s Year: 2004 Different relation between exhaled nitric oxide and lung function with regard to current smoking Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function Year: 2018 Pulmonary function test and fraction of exhaled nitric oxide of asthma in remission Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Exhaled nitric oxide as a marker of asthma control in smoking patients Source: Eur Respir J 2009; 33: 1295-1301 Year: 2009 Combined effects of type 2 inflammation and lung function on exhaled nitric oxide ability to reflect asthma control Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Levels of asthma control and exhaled nitric oxide Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 The influence of spirometry on the level of exhaled nitric oxide in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 569s Year: 2003 Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Fractional exhaled nitric oxide is associated with more severe asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Comparison of asthma control test and exhaled nitric oxide to predict asthma control Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010 Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007